(80) reported that treatment with teneligliptin, a dipeptidyl peptidase (DPP)–4 inhibitor, suppressed ANG II-induced increase in Nox4 mRNA in rat cardiomyocytes, thus attenuating the ANG II-induced cardiac hypertrophy. The gene discussed is AGT; the disease is cardiac hypertrophy.